Hormonal Contraception Access Through Pharmacist Prescribing Implementation
HAPPI (Hormonal Contraception Access Through Pharmacist Prescribing Implementation): Phase 2 (Aim 1)
EMPOWERX INC
150 participants
Oct 9, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to learn if use of the HAPPI software can improve pharmacist-provided birth control services. The main questions it aims to answer are: 1. Does the HAPPI software make it easier for pharmacists to provide birth control services in their pharmacy? 2. Does the HAPPI software make it easier for patients to access birth control? Researchers will compare pharmacists' implementation and patients' access when using the HAPPI software and when not using the HAPPI software to see if the software improves implementation and access. Participants will include pharmacists and patients. Pharmacists will be asked to provide birth control services as normal while using the HAPPI software. Patients will be asked to receive birth control services from a pharmacist as normal, while using the HAPPI software.
Eligibility
Inclusion Criteria7
- PHARMACIST Participants
- years of age or older
- Provide birth control services in a participating pharmacy
- Use the HAPPI software to provide birth control services
- years of age or older
- Seek birth control services at a participating pharmacy
- Use the HAPPI software to receive birth control services at a participating pharmacy
Exclusion Criteria3
- None
- PATIENT Participants
- NONE
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
We will enroll 15 community pharmacies. These 15 pharmacies will continue to provide birth control services as normal for several months (control). Then, we will introduce the intervention: the HAPPI software. The pharmacies will continue to provide birth control services while using the HAPPI software in place of any paper or electronic processes that they were previously using. The results will then be compared between the control and the intervention period.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06823037